Antipodes Partners LTD Certara, Inc. Transaction History
Antipodes Partners LTD
- $2.85 Billion
- Q4 2024
A detailed history of Antipodes Partners LTD transactions in Certara, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 5,442 shares of CERT stock, worth $55,236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,442
Previous 1,786
204.7%
Holding current value
$55,236
Previous $20,000
185.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CERT
# of Institutions
236Shares Held
114MCall Options Held
140KPut Options Held
5.7K-
Black Rock Inc. New York, NY13.4MShares$136 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$126 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.94MShares$90.7 Million0.48% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.88MShares$80 Million0.02% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO6.21MShares$63.1 Million0.99% of portfolio
About Certara, Inc.
- Ticker CERT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 159,899,008
- Market Cap $1.62B
- Description
- Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...